Pursuant to the provisions of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 [SEBI (LODR), 2015], Anuh Pharma has informed that it has enclosed the Compliance Certificate for the half year ended on March 31, 2020 jointly signed by authorised representative of Bigshare Services, Registrar and Share Transfer Agent of the Company certifying compliance with the requirements of Regulation 7(2) of the SEBI (LODR), 2015.
The above information is a part of company’s filings submitted to BSE.
